Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wireless and Mobile Monitoring: Bringing Health Care Home

Executive Summary

The recent proliferation of smart phones and mobile apps has put everything from face-to-face meetings to comparison shopping into the palms of our hands. Wireless technology is changing the way we communicate and do business, and proponents say it could soon have a similar game-changing impact on health care. Indeed, hundreds of mobile health apps are already available for relatively simple tasks such as logging and tracking blood pressure measurements, caloric intake, and sleep habits, but this is only the beginning of what could be a pervasive and increasingly sophisticated technology trend in the years ahead.

You may also be interested in...



Pioneering The New Mobile Health Paradigm: A Conversation With AliveCor’s David Albert, MD

A new, mobile monitoring technology has entered the cardiovascular market, and companies that already own a piece of the landscape are paying close attention to its debut. Start-up AliveCor Inc. has launched a heart rhythm monitor that works with smartphones – one of the first of a new breed of mobile medical devices that could have a disruptive impact on health care as it is performed today.

Heart Failure Devices: Raising Roadblocks To Readmission

A new Medicare cost-control program aimed at reducing costly hospital readmissions has heart failure squarely in the cross-hairs, and the consequences could mean hundreds of thousands of dollars in lost Medicare revenue for hospitals that fail to meet the new readmission standards. As a result, providers are scrambling to implement programs to assess and reduce heart failure readmissions, and a growing number of device companies are touting a variety of technologies they believe could help them achieve that goal.

Device Trends To Watch In 2012

For much of the device industry, 2011 was marked by continuing change across the medtech ecosystem, most notably in the economy, the regulatory process, and the financing/innovation model. For 2012, we predict more of the same: the only certainty is continuing uncertainty.

Related Content

Topics

Related Companies

Related Deals

Latest Headlines
See All
UsernamePublicRestriction

Register

MT035419

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel